The International Association for the Study of Lung Cancer Announces Abstract Selections for the 18th World Conference on Lung Cancer
(Thomson Reuters ONE) -
Groundbreaking research will shed light on the newest advances in the study of
lung cancer
DENVER, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The International Association for the
Study of Lung Cancer (IASLC) announced today the abstract selections for the
18th World Conference on Lung Cancer (WCLC), which will be held in Yokohama,
Japan, on October 15-18, 2017. The research will be presented during the
conference by world-class researchers, physicians, nurses and advocates from
around the globe, and will highlight the latest advancements in lung cancer
prevention and treatment and science across a number of different categories,
including surgery, radiotherapy, targeted therapies, immunotherapy, patient
advocacy and more.
"The groundbreaking research slated to be presented at this year's world
conference further strengthens our efforts to expand global education and
research on lung cancer," said Fred R. Hirsch, MD, PhD, Professor of Medicine
and Pathology at the University of Colorado Cancer Center and School of
Medicine, and CEO of the IASLC. "Our conference is unique because we are solely
dedicated to lung cancer and other thoracic malignancies, featuring research
from the best and brightest minds in the field from across all disciplines. This
collaborative spirit is critical to conquering lung cancer around the world."
A sampling of the abstracts for the 2017 WCLC include:
* Socioeconomic Factors Affecting Outcomes in Non-Small Cell Lung Cancer
(NSCLC): A Large Population-Based Analysis - Yanyan Lou, USA
* RESPECT-MESO: An International Randomised Controlled Trial to Assess Early
Specialist Palliative Care in Malignant Pleural Mesothelioma - Fraser Brims,
Australia
* Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT
Lung Cancer (LC) Screening - William Evans, Canada
* SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected
Patients. Final Survival Results a Spanish Lung Cancer Group Trial -
Bartomeu Massuti, Spain
* The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status
and Proposals for R Status Descriptors for Non-Small Cell Lung Cancer - John
Edwards, UK
* The Correlation of DLL3 Expression with High-Grade Pulmonary Neuroendocrine
Carcinoma Clinicopathologic Features and Prognoses - Li-Xu Yan, China
* Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally
Advanced, Unresectable NSCLC: Data from PACIFIC; Quality of life data on
radiation treatment with or without immunotherapy - Rina Hui, Australia
* Exercise Improves Functional Capacity in Patients with Advance Stage Lung
Cancer - Morten Quist, Denmark
* Reducing Lung Cancer Mortality in Disparate Populations through Cancer-
Community Awareness Access Research and Education (C-CARE) - Lovoria
Williams, USA
The abstracts listed above will be featured in the press program. For the full
list of abstracts, visit the 2017 WCLC website here.
About the WCLC:
The World Conference on Lung Cancer (WCLC) is the world's largest meeting
dedicated to lung cancer and other thoracic malignancies, attracting over 6,000
researchers, physicians and specialists from more than 100 countries. The goal
is to disseminate the latest scientific achievements; increase awareness,
collaboration and understanding of lung cancer; and to help participants
implement the latest developments across the globe. Organized under the theme of
"Synergy to Conquer Lung Cancer," the conference will cover a wide range of
disciplines and unveil several research studies and clinical trial results. For
more information, visit http://wclc2017.iaslc.org/.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only
global organization dedicated to the study of lung cancer and other thoracic
malignancies. Founded in 1974, the association's membership includes more than
6,500 lung cancer specialists across all disciplines in over 100 countries,
forming a global network working together to conquer lung and thoracic cancers
worldwide. The association also publishes the Journal of Thoracic Oncology, the
primary educational and informational publication for topics relevant to the
prevention, detection, diagnosis and treatment of all thoracic malignancies.
Visit www.iaslc.org for more information.
Contact:
Hillary Wasserman
+1 212-784-5726
hwasserman(at)groupgordon.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IASLC via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 07.09.2017 - 20:17 Uhr
Sprache: Deutsch
News-ID 559233
Anzahl Zeichen: 5314
contact information:
Town:
Aurora, Colorado
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 234 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The International Association for the Study of Lung Cancer Announces Abstract Selections for the 18th World Conference on Lung Cancer"
steht unter der journalistisch-redaktionellen Verantwortung von
IASLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
